참고문헌
- Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522 https://doi.org/10.1016/j.cell.2005.02.003
- Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16 https://doi.org/10.1038/358015a0
- Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 https://doi.org/10.1016/S0092-8674(00)81871-1
- Vousden KH and Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2, 594-604 https://doi.org/10.1038/nrc864
- Haupt Y, Maya R, Kazaz A and Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 https://doi.org/10.1038/387296a0
- Kubbutat MH, Jones SN and Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303 https://doi.org/10.1038/387299a0
- Charni M, Aloni-Grinstein R, Molchadsky A and Rotter V (2017) p53 on the crossroad between regeneration and cancer. Cell Death Differ 24, 8-14 https://doi.org/10.1038/cdd.2016.117
- Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17, 554-564 https://doi.org/10.1093/emboj/17.2.554
- Wei N and Deng XW (1999) Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 15, 98-103 https://doi.org/10.1016/S0168-9525(98)01670-9
- Tomoda K, Kubota Y, Arata Y et al (2002) The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277, 2302-2310 https://doi.org/10.1074/jbc.M104431200
- Doronkin S, Djagaeva I and Beckendorf SK (2003) The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev Cell 4, 699-710 https://doi.org/10.1016/S1534-5807(03)00121-7
- Kim BC, Lee HJ, Park SH et al (2004) Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol 24, 2251-2262 https://doi.org/10.1128/MCB.24.6.2251-2262.2004
- Callige M, Kieffer I and Richard-Foy H (2005) CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. Mol Cell Biol 25, 4349-4358 https://doi.org/10.1128/MCB.25.11.4349-4358.2005
- Lee EW, Oh W and Song J (2006) Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53. Mol Cells 22, 133-140
- Oh W, Lee EW, Sung YH et al (2006) Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 281, 17457-17465 https://doi.org/10.1074/jbc.M601857200
- Oh W, Yang MR, Lee EW et al (2006) Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem 281, 30166-30174 https://doi.org/10.1074/jbc.M602651200
- Kim JH, Choi JK, Cinghu S et al (2009) Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. J Cell Biochem 107, 557-565 https://doi.org/10.1002/jcb.22157
- Guo H, Jing L, Cheng Y et al (2016) Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis. Hepatology 63, 898-913 https://doi.org/10.1002/hep.28372
- Lu R, Hu X, Zhou J et al (2016) COPS5 amplification and overexpression confers tamoxifen-resistance in ERalphapositive breast cancer by degradation of NCoR. Nat Commun 7, 12044 https://doi.org/10.1038/ncomms12044
- Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S and Kato JY (2004) Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 279, 43013-43018 https://doi.org/10.1074/jbc.M406559200
- Bech-Otschir D, Kraft R, Huang X et al (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20, 1630-1639 https://doi.org/10.1093/emboj/20.7.1630
- Yang WH, Kim JE, Nam HW et al (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8, 1074-1083 https://doi.org/10.1038/ncb1470
- Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ and Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18, 1660-1672 https://doi.org/10.1093/emboj/18.6.1660
- Carter S, Bischof O, Dejean A and Vousden KH (2007) C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9, 428-435 https://doi.org/10.1038/ncb1562
- Lohrum MA, Woods DB, Ludwig RL, Balint E and Vousden KH (2001) C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21, 8521-8532 https://doi.org/10.1128/MCB.21.24.8521-8532.2001
- Li M, Brooks CL, Wu-Baer F, Chen D, Baer R and Gu W (2003) Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975 https://doi.org/10.1126/science.1091362
- Coutts AS, Adams CJ and La Thangue NB (2009) p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst) 8, 483-490 https://doi.org/10.1016/j.dnarep.2009.01.008
- Boyd SD, Tsai KY and Jacks T (2000) An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2, 563-568 https://doi.org/10.1038/35023500
- Geyer RK, Yu ZK and Maki CG (2000) The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2, 569-573 https://doi.org/10.1038/35023507
- Dai C and Gu W (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 16, 528-536 https://doi.org/10.1016/j.molmed.2010.09.002
- Cai X and Liu X (2008) Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage. Proc Natl Acad Sci U S A 105, 16958-16963 https://doi.org/10.1073/pnas.0804608105
- Brooks CL and Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21, 307-315 https://doi.org/10.1016/j.molcel.2006.01.020
- Lee EW, Lee MS, Camus S et al (2009) Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J 28, 2100-2113 https://doi.org/10.1038/emboj.2009.164
- Seo J, Lee EW, Sung H et al (2016) CHIP controls necroptosis through ubiquitylation- and lysosomedependent degradation of RIPK3. Nat Cell Biol 18, 291-302 https://doi.org/10.1038/ncb3314
- Lee EW, Kim JH, Ahn YH et al (2012) Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun 3, 978 https://doi.org/10.1038/ncomms1981